C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) A61K 39/395 (2006.01) C07K 14/48 (2006.01) C07K 14/61 (2006.01) C07K 16/00 (2006.01) C07K 16/28 (2006.01) C07K 16/46 (2006.01) C07K 19/00 (2006.01) C12N 15/62 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2217871
Polypeptides that are cleared from the kidney and do not contain in their original form an Fc region of an IgG are altered so as to comprise a salvage receptor binding epitope of an Fc region of an IgG and thereby have increased circulatory half-life.
La présente invention concerne la modification de polypeptides qui sont éliminés par le rein et qui ne possèdent pas une région Fc d'IgG dans leur forme originale, laquelle modification consiste en l'introduction d'un épitope d'une région Fc d'IgG permettant une liaison à un récepteur dit de sauvetage, ce qui accroît la demi-vie desdits polypeptides dans la circulation.
Presta Leonard G.
Snedecor Bradley R.
Dennison Associates
Genentech Inc.
LandOfFree
Altered polypeptides with increased half-life does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Altered polypeptides with increased half-life, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Altered polypeptides with increased half-life will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1679208